**Author details**

Wei Zheng\* and Boya Deng Department of Gynecology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China

\*Address all correspondence to: zhengwei@zju.edu.cn

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**81**

*Adenomyosis*

**References**

425-441

139-147

*DOI: http://dx.doi.org/10.5772/intechopen.90942*

[1] McElin TW, Bird CC. Adenomyosis

epithelial and stromal cells. Biology of Reproduction. 2004;**70**(6):1738-1750

[10] Gargett CE, Schwab KE, Deane JA. Endometrial stem/progenitor cells: The first 10 years. Human Reproduction

[11] Chen YJ et al. Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis. The Journal of Pathology.

[12] Chapron C et al. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes. Human Reproduction. 2017;**32**(7):1393-1401

[13] Brucker SY et al. Clinical

coexisting with leiomyomas: A retrospective, questionnairebased study. Fertility and Sterility.

2014;**101**(1):237-241.e1

2011;**18**(4):428-437

characteristics indicating adenomyosis

[14] Di Donato N et al. Prevalence of adenomyosis in women undergoing surgery for endometriosis. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2014;**181**:289-293

[15] Garcia L, Isaacson K. Adenomyosis: Review of the literature. Journal of Minimally Invasive Gynecology.

[16] Rasmussen CK, Hansen ES, Dueholm M. Inter-rater agreement in the diagnosis of adenomyosis by 2- and 3-dimensional transvaginal ultrasonography. Journal of Ultrasound in Medicine. 2019;**38**(3):657-666

[17] Nelson JR, Corson SL. Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: A case report. Fertility and Sterility. 1993;**59**(2):441-443

Update. 2016;**22**(2):137-163

2010;**222**(3):261-270

Timmerman D. Uterine adenomyosis in the infertility clinic. Human Reproduction Update. 2003;**9**(2):

[3] Ibrahim MG et al. Myofibroblasts are evidence of chronic tissue microtrauma

adenomyosis. Reproductive Sciences.

[4] Vannuccini S et al. Pathogenesis of adenomyosis: An update on molecular mechanisms. Reproductive Biomedicine

[5] Ren Y et al. Decreased expression of Beclin 1 in eutopic endometrium of women with adenomyosis. Archives of Gynecology and Obstetrics.

at the endometrial-myometrial junctional zone in uteri with

2017;**24**(10):1410-1418

Online. 2017;**35**(5):592-601

2010;**282**(4):401-406

2019;**215**(8):152477

2009;**280**(4):529-538

2011;**5**(2):125-142

[8] Leyendecker G, Wildt L. A new concept of endometriosis and adenomyosis: Tissue injury and repair (TIAR). Hormone Molecular Biology and Clinical Investigation.

[9] Chan RW, Schwab KE, Gargett CE. Clonogenicity of human endometrial

[6] Li J et al. The expression of Bcl-2 in adenomyosis and its effect on proliferation, migration, and apoptosis of endometrial stromal cells. Pathology, Research and Practice.

[7] Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: Tissue injury and repair. Archives of Gynecology and Obstetrics.

of the uterus. Obstetrics and Gynecology Annual. 1974;**3**(0):

[2] Devlieger R, D'Hooghe T,
